LetterLetter
Clinical Utility of Antipeptidyl Arginine Deiminase Type 4 Antibodies
Erika Darrah, Laura Martinez-Prat and Michael Mahler
The Journal of Rheumatology January 2019, jrheum.180905; DOI: https://doi.org/10.3899/jrheum.180905
Erika Darrah
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Research and Development, Inova Diagnostics Inc.; Research and Development, Inova Diagnostics Inc., San Diego, California, USA. E. Darrah is an author on licensed patent no. 8,975,033 entitled “Human Autoantibodies Specific for PAD3 which are Cross-reactive with PAD4 and their Use in the Diagnosis and Treatment of Rheumatoid Arthritis and Related Diseases”. Address correspondence to M. Mahler, Inova Diagnostics, 9900 Old Grove Road, San Diego, California 32131-1638, USA. E-mail: mmahler@inovadx.com or m.mahler.job@web.de
Laura Martinez-Prat
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Research and Development, Inova Diagnostics Inc.; Research and Development, Inova Diagnostics Inc., San Diego, California, USA. E. Darrah is an author on licensed patent no. 8,975,033 entitled “Human Autoantibodies Specific for PAD3 which are Cross-reactive with PAD4 and their Use in the Diagnosis and Treatment of Rheumatoid Arthritis and Related Diseases”. Address correspondence to M. Mahler, Inova Diagnostics, 9900 Old Grove Road, San Diego, California 32131-1638, USA. E-mail: mmahler@inovadx.com or m.mahler.job@web.de
Michael Mahler
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Research and Development, Inova Diagnostics Inc.; Research and Development, Inova Diagnostics Inc., San Diego, California, USA. E. Darrah is an author on licensed patent no. 8,975,033 entitled “Human Autoantibodies Specific for PAD3 which are Cross-reactive with PAD4 and their Use in the Diagnosis and Treatment of Rheumatoid Arthritis and Related Diseases”. Address correspondence to M. Mahler, Inova Diagnostics, 9900 Old Grove Road, San Diego, California 32131-1638, USA. E-mail: mmahler@inovadx.com or m.mahler.job@web.de
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Clinical Utility of Antipeptidyl Arginine Deiminase Type 4 Antibodies
Erika Darrah, Laura Martinez-Prat, Michael Mahler
The Journal of Rheumatology Jan 2019, jrheum.180905; DOI: 10.3899/jrheum.180905